Condition: Idiopathic Pulmonary Fibrosis · Sponsor: siRNAgen Therapeutics Inc.
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of SRN001 in healthy adult volunteers.
This description comes directly from the study's public registry record.
Eunkyeong Woo · +82-42-930-8654 · wek@sirnagen.com
Always discuss trial participation with your own doctor first.
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07407543